胫骨平台骨折合并周围韧带损伤治疗探讨

目的 分析胫骨平台骨折术后随访病例膝关节稳定性的变化，探讨胫骨平台骨折合并周围韧带损伤的发生率及早期诊断和处理措施。方法 对2000年1月～2003年6月期间在我院治疗的不同类型胫骨平台骨折进行回顾，对有随访的57例良好复位的平台骨折病例膝关节稳定度进行分析。结果 随访6个月～2.5年，平均15个月，未见明显膝关节不稳现象，总结出本组病例膝关节稳定性良好的原因：①胫骨平台骨折合并周围韧带损伤发生率低；②胫骨平台骨折合并韧带损伤程度轻；③解剖复位及坚强内固定；④术后良好制动及正确的康复训练指导。结论 胫骨平台骨折合并周围韧带完全断裂的发生率较低，韧带不全损伤非手术治疗可获得良好疗效。     

肝移植围手术期出凝血功能障碍的防治

目的　探讨肝移植围手术期出凝血功能障碍的防治。方法　回顾性分析我院 2 0 0 2年 6月～ 2 0 0 3年 12月施行的 6 1例肝移植病例。结果　 6 1例肝移植术前肝功能ChildC级 35例 (5 7 4 % ) ,ChildB级 2 6例 (4 2 6 % ) ,ChildC组的患者术中凝血指标 (INR)的变化程度大于ChildB组 (P <0 0 5 )。与凝血有关的并发症中大出血 5例 (8 2 % ) ,肾衰 6例 (9 8% ) ,肝动脉血栓形成 5例 (8 2 % ) ,手术开展两阶段对比 ,第二阶段主要因限制了大量凝血药及血制品的使用 ,并发症明显减少。结论　掌握好不同时期、不同患者出血和血栓形成的平衡是防治肝移植围手术期出凝血功能障碍的关键     

Effect of rs1063843 in the CAMKK2 gene on the dorsolateral prefrontal cortex

Recently, a single nucleotide polymorphism (SNP) in the CAMKK2 gene (rs1063843) was found to be associated with lower expression of the gene in the dorsolateral prefrontal cortex (DLPFC) and with schizophrenia (SCZ) and deficits in working memory and executive function. However, the brain mechanism underlying this association is poorly understood. A functional magnetic resonance imaging (fMRI) study (N = 84 healthy volunteers) involving multiple cognitive tasks, including a Stroop task (to measure attentional executive control), an N‐back task (to measure working memory), and a delay discounting task (to measure decision making) to identify the brain regions affected by rs1063843 was performed. Across all three tasks, it was found that carriers of the risk allele consistently exhibited increased activation of the left DLPFC. In addition, the risk allele carriers also exhibited increased activation of the right DLPFC and the left cerebellum during the Stroop task and of the left caudate nucleus during the N‐back task. These findings helped to elucidate the role of CAMKK2 in cognitive functions and in the etiology of SCZ. Hum Brain Mapp 37:2398–2406, 2016. © 2016 Wiley Periodicals, Inc .     

Association between angiotensin-converting enzyme insertion/deletion polymorphism and migraine: a meta-analysis

Background: Many studies investigated the association between angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism and migraine, with controversial results. Thus, we performed a meta-analysis to better evaluate the correlation of this polymorphism and migraine. Methods: We retrieved studies published up to September 2014 about the ACE gene polymorphism and migraine from electronic database. Pooled odds ratios (ORs) with 95% confidence interval (CI) were calculated to examine the strength of association between the ACE I/D polymorphism and migraine, using random-effects models. Results: We identified 14 separate studies, in which 7334 migraineurs and 22 990 healthy controls were eligible for the meta-analysis. The results showed no relationship between the ACE I/D polymorphism and any migraine. Stratification revealed a protective effect in the Turkish population against migraine with aura for the II genotype model (II vs. DD: pooled OR = 0.366, 95% CI = 0.137–0.980; II vs. DI + DD: pooled OR = 0.370, 95% CI = 0.145–0.945). Similar results were obtained for Turkish people with migraine without aura (II vs. DD: pooled OR = 0.386; 95% CI = 0.166–0.900; II vs. DI + DD: pooled OR = 0.347; 95% CI = 0.156–0.773). Conclusions: The data suggest that the ACE II genotype could exert a protective effect against migraine with aura and without aura at least in the Turkish population.     

18F-FDG PET/CT对皮肌炎抗MDA5抗体及预后的预测价值

目的:分析抗黑色素瘤分化相关基因5(MDA5)抗体阳性皮肌炎患者的肌肉FDG代谢、肿瘤发生率以及肺间质性改变在¹⁸F-FDG PET/CT的影像特征及其鉴别抗MDA5抗体阳性皮肌炎的价值。 方法:回顾性分析2016年6月至2019年7月在上海交通大学医学院附属仁济医院接受¹⁸F-FDG PET/CT检查的75例(34例抗MDA5抗体阳性,41例抗MDA5抗体阴性)皮肌炎患者[男21例、女54例,年龄(52.3±14.3)岁]和30名健康对照者[男10名、女20名,年龄(53.5±11.8)岁]的影像和临床资料,测定并计算肌肉SUV max及肌肉SUV max平均值(mSUV max);统计皮肌炎患者合并肿瘤性病变的情况;测定皮肌炎合并间质性肺炎患者肺炎病灶的SUV max。采用两独立样本 t检验、单因素方差分析、SNK检验和 χ²检验分析数据;行ROC曲线分析肌肉mSUV max鉴别抗MDA5抗体阳性皮肌炎的诊断效能。 结果:健康对照者、抗MDA5抗体阳性和抗MDA5抗体阴性皮肌炎患者的肌肉mSUV max分别为0.39±0.05、0.66±0.21和0.87±0.29( F=39.93, P<0.001);皮肌炎患者的肌肉mSUV max均高于健康对照者( q值:6.76、12.63,均 P<0.001);抗MDA5抗体阴性患者高于抗MDA5抗体阳性患者( q=5.79, P<0.001)。ROC AUC为0.74,当肌肉mSUV max取最佳阈值0.75时,在皮肌炎中鉴别出抗MDA5抗体阳性的准确性为74.7%(56/75)。抗MDA5抗体阴性患者中,恶性肿瘤6例(14.6%,6/41);抗MDA5抗体阳性患者中,无恶性肿瘤病例(0/34;χ²=5.41, P=0.020)。抗MDA5抗体阴性伴发间质性肺炎11例(26.8%, 11/41),抗MDA5抗体阳性伴发间质性肺炎33例(97.1%, 33/34;χ²=37.81, P<0.001);抗MDA5抗体阳性患者肺炎FDG代谢高于抗MDA5抗体阴性患者(SUV max:3.65±1.83和2.38±1.27;t=2.13, P=0.039)。 结论:抗MDA5抗体阳性皮肌炎患者的肌肉FDG代谢高于健康对照者,但低于抗MDA5抗体阴性患者。抗MDA5抗体阳性患者肿瘤性病变发生率低于抗MDA5抗体阴性患者。抗MDA5抗体阳性患者发生间质性肺炎的比例和严重程度均高于阴性患者。¹⁸F-FDG PET/CT对于鉴别抗MDA5抗体阳性皮肌炎具有一定价值。     

Teriparatide and the risk of nonvertebral fractures in women with postmenopausal osteoporosis

Purpose

In the Fracture Prevention Trial, the risks of any nonvertebral fracture (relative risk [RR] 0.65, P = 0.04) and any fragility nonvertebral fracture (RR 0.47, P = 0.02) were significantly reduced in the teriparatide 20 μg/day (teriparatide) versus placebo group. The purpose of this analysis was to examine the efficacy of teriparatide versus placebo on a variety of other nonvertebral fracture outcomes.

Materials and methods

The Fracture Prevention Trial was a double-blind trial of postmenopausal women with osteoporosis and vertebral fractures randomly assigned to teriparatide (N = 541) or placebo (N = 544) administered by daily self-injection for a median of 19 months and a median follow-up of 21 months. All patients received calcium and vitamin D supplementation. Reports of nonvertebral fractures were collected from patients at each visit and confirmed by review of a radiograph or written radiology report. Nonvertebral fractures were recorded for the following sites: distal radius/wrist, humerus, rib/clavicle, hip, ankle, distal foot, pelvis, or other. Pathological fractures and fractures of the face, skull, metacarpals, fingers and toes were excluded. Fractures were classified by investigators as fragility or traumatic fractures. The three endpoints considered were six nonvertebral sites (nonvert-6), a set of common nonvertebral fractures described in a Food and Drug Administration Guidance document for the treatment and prevention of postmenopausal osteoporosis (FDA), and a European Union major set (major) of nonvertebral fractures.

Results

For teriparatide versus placebo, the point estimates for the RR of nonvert-6 (RR 0.54, P = 0.06; fragility RR 0.32, P = 0.014), FDA (RR 0.60, P = 0.15; fragility RR 0.38, P = 0.05), and major (RR 0.52, P = 0.02; fragility RR 0.38, P = 0.02) nonvertebral fracture endpoints were smaller than for the all nonvertebral fracture endpoint. Lower RRs were observed when the outcomes were limited to fragility fractures, and significant reductions in traumatic nonvertebral fractures were not observed.

Conclusion

In the Fracture Prevention Trial, the risk reduction for nonvertebral fracture in patients treated with teriparatide versus placebo depended on the set of nonvertebral fractures included in the analysis; lower RRs were observed for nonvertebral fractures most likely to be of osteoporotic origin. No significant reductions in traumatic nonvertebral fractures were observed.     

扁平化管理在妇科优质护理服务中的实施

目的在优质护理服务过程中进一步提高护理管理及护理服务满意度。方法在妇科病区采用扁平化管理模式,即取消责任护士组长,按3个管床教授组将病区18名护士均分为3组,每组A班(7:30～17:00)2人,N班(17:00～8:00)1人,轮休3人;每人分管患者≤8例,另6名护理人员分别上辅助班、计算机操作班及主班等。每个月按护理部制定的标准进行护理质控,实施10个月后评价效果。结果患者对优质护理服务及责任护士知晓率≥95%,入院介绍、技术操作等10项满意度评分9.28～9.66分,均为满意和非常满意。结论扁平化管理模式的运用有利于护理人力资源的合理利用,从而提高护理质量和患者满意度。     

Changes in vitamin D metabolites during teriparatide treatment

Parathyroid hormone (PTH) increases the conversion of 25-hydroxyvitamin D [25(OH)D] to 1,25 dihydroxyvitamin D [1,25(OH)(2)D]. The purpose of this study was to assess the changes in serum concentration of vitamin D metabolites 1,25 dihydroxyvitamin D [1,25(OH)(2)D] and 25-hydroxyvitamin D [25(OH)D] during teriparatide 20 μg/day (teriparatide) therapy in the double-blind Fracture Prevention Trial of postmenopausal women with osteoporosis and in the male study of men with osteoporosis. Patients were randomized to teriparatide or placebo and received daily supplements of calcium 1000 mg and vitamin D 400-1200 IU. Serum concentrations of 1,25(OH)(2)D and 25(OH)D were measured. In women (N=336), median 1,25(OH)(2)D concentrations at 1 month increased from baseline by 27% (P<0.0001) in the teriparatide group versus -3% (P=0.87) in the placebo group (between group P<0.0001). At 12 months, the increase was 19% (P<0.0001) in the teriparatide group versus -2% (P=0.23) in the placebo group (P<0.0001). Median 25(OH)D concentrations at 12 months decreased by 19% (P<0.0001) in the teriparatide group versus 0% (P=0.13) in the placebo group (P<0.0001). In men (N=287), median 1,25(OH)(2)D concentrations at 1 month increased by 22% (P<0.0001) in the teriparatide group versus 0% (P=0.99) in the placebo group (P<0.0001). At 12 months, the increase was 14% (P<0.0001) in the teriparatide group versus 5% (P=0.004) in the placebo group (P=0.17). Median 25(OH)D concentrations at 12 months decreased by 11% (P=0.001) in the teriparatide group versus an increase of 1% (P=0.20) in the placebo group (P=0.003). Therefore, treatment with teriparatide increases 1,25(OH)(2)D concentrations and decreases 25(OH)D concentrations.     

The washout rate on the delayed CT image as a diagnostic tool for adrenal adenoma verified by pathology: a multicenter study

Objectives

To establish the undisputed the value of washout rate for adrenal adenoma using delayed enhanced CT, we evaluated diagnostic performance of cut-off value and delayed time of washout rate by final pathologic diagnosis in a multicenter study.

Methods

We reviewed the pathologic and clinical records of 244 patients underwent adrenalectomies at 5 university hospitals between 2005 and 2009. We calculated the mean Housfield units (HU) of adrenal lesion at non-enhancing CT, and early and delayed enhanced CT using the region of interest. We used ROC curves to determine the specificity and sensitivity of non-enhanced CT scans and the washout rate according to the various cut-off for adrenal adenomas.

Results

We divided the patients into adrenal adenoma group (n?=?138) and non-adrenal adenoma group (n?=?106) based on final pathologic report. Using the unenhanced images with a threshold of 10 HU, the sensitivity was 45.7?%, and the specificity was 97.1?%. Using the 15-min-washout rate with a threshold of 55?%, the sensitivity was 93.9?%, and the specificity was 95.8?%.

Conclusions

Regardless of various CT machines and protocols, a washout rate of 15-min-delayed CT was most useful in the diagnosis of adrenal adenomas due to the early inflow and outflow of contrast media in the tissues of adrenal adenomas.     

Choices of Surgical Approaches for Gastrointestinal Stromal Tumors of the Stomach: Laparoscopic versus Open Resection

Aims: The aim of this study is to explore the optimal surgical approach for gastrointestinal stromal tumors (GISTs) of the stomach in terms of the perioperative outcomes and long-term relapse-free survival. Methods: From January 2004 to July 2011, 156 patients who underwent either laparoscopic (LAP group, n = 68) or open surgery (OPEN group, n = 88) were included in the final analysis following the eligibility criteria. Results: Clinicopathological characteristics of the selected patients were similar between the two groups. The LAP group was associated with less blood loss (50 vs. 180 ml, p < 0.001), shorter operating time (90 vs. 125 min, p < 0.001), earlier oral intake (3 vs. 5 days, p < 0.001), shorter postoperative hospital stay (8 vs. 10 days, p < 0.001), and low risk of postoperative complications (5.9 vs. 22.7%, p = 0.004) compared with the OPEN group. No significant difference was observed in 5-year relapse-free survival between the LAP and OPEN groups (94.2 vs. 94.0%, p = 0.807). The subgroup analysis of patients who underwent wedge resection showed similar results with the original comparison except that difference in complication rate between the two groups lost significance. Conclusions: Laparoscopic wedge resection for gastric GISTs ≤7 cm could get preferable short-term postoperative outcomes and similar long-term relapse-free survival compared with open surgery.